Stay updated on Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Sign up to get notified when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3, indicating a minor platform/template update. This change does not alter the trial details or user-facing content.
    Difference
    0.1%
    Check dated 2026-07-04T09:21:57.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.6.2 was added to the page, replacing Revision: v3.6.0. This change represents a version update with no impact on the study content or user interactions.
    Difference
    0.1%
    Check dated 2026-06-27T05:38:27.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    No textual changes are reflected in the available data. The study details page content appears unchanged.
    Difference
    0.1%
    Check dated 2026-06-20T03:22:53.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The study details page adds navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and a version stamp (Revision: v3.6.0). The legacy labels and the formatting of the contact line were removed or adjusted (e.g., Last known status, the Daniela Katz M.D. line).
    Difference
    2%
    Check dated 2026-06-12T23:49:11.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page shows a revision tag updated from v3.5.4 to v3.5.5, signaling a new build or template version. This is a metadata update rather than a change to visible content, functionality, or data on the page.
    Difference
    0.2%
    Check dated 2026-06-05T17:13:40.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    No changes were provided in the data, so there are no additions or deletions to evaluate on the page context.
    Difference
    0.1%
    Check dated 2026-05-29T14:44:53.000Z thumbnail image

Stay in the know with updates to Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.